Release – Gevo to Sell Renewable Natural Gas to bp


Gevo to Sell Renewable Natural Gas to bp

 

ENGLEWOOD, Colo., Aug. 09, 2021 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO), is extremely pleased to announce today that its wholly-owned dairy manure-based renewable natural gas (“RNG”) project company located in northwest Iowa, Gevo NW Iowa RNG, LLC (“NW Iowa RNG”), has signed binding, definitive agreements with BP Canada Energy Marketing Corp. and BP Products North America Inc. (collectively, “bp” ) for the sale of NW Iowa RNG’s production (the “bp Agreements”).
 

The NW Iowa RNG project is currently being constructed and is expected to commence production in early 2022. Upon project completion, NW Iowa RNG is estimated to produce approximately 355,000 MMBtu of RNG per year. The RNG is expected to be sold into the California market under dispensing agreements bp has in place with Clean Energy Fuels Corp., the largest fueling infrastructure in the U.S. for RNG.

RNG-fueled vehicles are estimated to result in up to 95 percent lower emissions than those fueled by gasoline or diesel on a lifecycle basis, according to a US Department of Energy study .

It is anticipated that NW Iowa RNG will benefit from environmental product revenues under California’s Low Carbon Fuel Standard program and the U.S. Environmental Protection Agency’s Renewable Identification Number program.

Beginning in late 2022 upon stabilized operations and pathway certifications of its environmental products, NW Iowa RNG is expected to generate cash distributions to Gevo of approximately $9 to $16 million per year. Starting in 2024, Gevo will have the right to use a portion of NW Iowa RNG’s production as process energy at its Net-Zero 1 Project or other production facilities, including future Net-Zero projects.

“RNG is proving to be a key fuel in the energy transition. bp has a value chain that allows RNG to reach the transportation market, and it’s a pleasure to work with a company that shares our vision of a low-carbon future,” said Dr. Patrick R. Gruber, Chief Executive Officer of Gevo. “This is an excellent opportunity to meet the growing demand for RNG and to expand our RNG business. We are glad to be working with bp.”

For more information and details about the terms of the bp Agreements, please see the Current Report on Form 8-K that Gevo has filed with the U.S. Securities and Exchange Commission on August 9, 2021.

About Gevo

Gevo’s mission is to transform renewable energy and carbon into energy-dense liquid hydrocarbons. These liquid hydrocarbons can be used for drop-in transportation fuels such as gasoline, jet fuel and diesel fuel, that when burned have potential to yield net-zero greenhouse gas emissions when measured across the full life cycle of the products. Gevo uses low-carbon renewable resource-based carbohydrates as raw materials, and is in an advanced state of developing renewable electricity and renewable natural gas for use in production processes, resulting in low-carbon fuels with substantially reduced carbon intensity (the level of greenhouse gas emissions compared to standard petroleum fossil-based fuels across their life cycle). Gevo’s products perform as well or better than traditional fossil-based fuels in infrastructure and engines, but with substantially reduced greenhouse gas emissions. In addition to addressing the problems of fuels, Gevo’s technology also enables certain plastics, such as polyester, to be made with more sustainable ingredients. Gevo’s ability to penetrate the growing low-carbon fuels market depends on the price of oil and the value of abating carbon emissions that would otherwise increase greenhouse gas emissions. Gevo believes that its proven, patented technology enabling the use of a variety of low-carbon sustainable feedstocks to produce price-competitive low-carbon products such as gasoline components, jet fuel and diesel fuel yields the potential to generate project and corporate returns that justify the build-out of a multi-billion-dollar business.

Gevo believes that the Argonne National Laboratory GREET model is the best available standard of scientific-based measurement for life cycle inventory or LCI.

Learn more at Gevo’s website: www.gevo.com

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters including, without limitation, the development and construction of the the NW Iowa RNG project, the bp Agreements, the ability of Gevo to realize production of RNG with NW Iowa RNG, Gevo’s ability to generate cash from NW Iowa RNG, and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2020, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.

Investor and Media Contact

+1 720-647-9605

IR@gevo.com

Release – QuoteMedia Q2 2021 Financial Results and Investors Conference Call August 12 2021


QuoteMedia Q2 2021 Financial Results and Investors’ Conference Call August 12, 2021

 

PHOENIX, Aug. 09, 2021 (GLOBE NEWSWIRE) — QuoteMedia, Inc. (OTCQB: QMCI), a leading provider of market data and financial applications, today announced that its earnings for its quarter ended June 30, 2021 will be released the morning of August 12, 2021. That same day, the company will host a conference call at 2:00 PM Eastern time to discuss the financial results and provide a business update.

Conference Call Details:

Date: August 12, 2021

Time: 2:00 PM Eastern

Dial-in numbers: 877-876-9173

Conference ID: QUOTEMEDIA

An audio rebroadcast of the call will be available later at: www.quotemedia.com

About QuoteMedia

QuoteMedia is a leading software developer and cloud-based syndicator of financial market information and streaming financial data solutions to media, corporations, online brokerages, and financial services companies. The Company licenses interactive stock research tools such as streaming real-time quotes, market research, news, charting, option chains, filings, corporate financials, insider reports, market indices, portfolio management systems, and data feeds. QuoteMedia provides data and services for companies such as the Nasdaq Stock Exchange, TMX Group (TSX Stock Exchange), Canadian Securities Exchange (CSE), London Stock Exchange Group, FIS, U.S. Bank, Broadridge Financial Systems, JPMorgan Chase, CI Financial, Canaccord Genuity Corp., Hilltop Securities, HD Vest, Stockhouse, Zacks Investment Research, General Electric, Boeing, Bombardier, Business Wire, PR Newswire, FolioFN, Regal Securities, ChoiceTrade, Cetera Financial Group, Dynamic Trend, Inc., Qtrade Financial, CNW Group, Industrial Alliance, Ally Invest, Inc., Suncor, Virtual Brokers, Equities.com, Leede Jones Gable, Firstrade Securities, Charles Schwab, First Financial, Cirano, Equisolve, Stock-Trak, Mergent, Cision, Warrior Trading and others. Quotestream® , QMod™ and Quotestream Connect™ are trademarks of QuoteMedia. For more information, please visit www.quotemedia.com..

QuoteMedia Investor Relations
Brendan Hopkins
Email: investors@quotemedia.com
Call: (407) 645-5295

Release – Eagle Bulk Shipping Inc. Reports Second Quarter 2021 Results


Eagle Bulk Shipping Inc. Reports Second Quarter 2021 Results

 

STAMFORD, Conn.
Aug. 05, 2021 (GLOBE NEWSWIRE) — 
Eagle Bulk Shipping Inc. (NASDAQ: EGLE) (“Eagle Bulk”, “Eagle” or the “Company”), one of the world’s largest owner-operators within the drybulk vessel segment, today reported financial results for the quarter ended 
June 30, 2021.

Quarter highlights:

  • Operated an average of 50 owned vessels for the quarter.

  • Revenues, net of 
    $129.9 million

    • Generated TCE Revenue (1) of 
      $93.4 million
    • Achieved TCE (1) of 
      $21,580/day for the quarter

  • Realized a net income of 
    $9.2 million, or 
    $0.76 and 
    $0.74 per basic and diluted share, respectively

    • Adjusted net income(1) of 
      $40.3 million, or 
      $3.31(1) and 
      $2.63(1) per adjusted basic and diluted share, respectively
  • Realized Adjusted EBITDA(1) of 
    $62.7 million

  • Raised net proceeds of 
    $27.4 million in new equity under the Company’s ATM program at a weighted average share price of 
    $47.97 per share.

  • Executed agreements to purchase two 2015-built scrubber-fitted Ultramax bulkcarriers for total consideration of 
    USD 44 million.

  • Took delivery of three previously announced vessel acquisitions.

  • Published 2021 ESG Sustainability Report.

Recent Developments:

  • Looking ahead, fixed 75% of Q3 2021 available days at an average TCE of 
    $28,300 as of 
    August 5, 2021

Eagle’s CEO  Gary Vogel commented, “The market for the midsize drybulk segment continued to strengthen in the second quarter on the back of robust demand across the commodity spectrum, and especially for grain and infrastructure-related cargoes that we carry such as cement, manganese ore, and steel.

We achieved our best ever operating performance, producing an adjusted EBITDA of over 
$62 million, as the Baltic Supramax Index rose by almost 60% during the quarter, reaching levels not seen in more than a decade.

In parallel with spot rate development, asset prices have rallied strongly in recent months, with values for mid-aged vessels having increased by about 75% since the beginning of the year. This has had a profound impact on the valuation of our 53-ship fleet, including the nine vessels we acquired since December of last year.

Looking ahead, our TCE has continued to climb, and as of today, we have covered approximately 75% of our available days for the third quarter at a net TCE in excess of 
$28,000. Given both positive demand and historically low supply side fundamentals, we maintain an optimistic outlook on market developments going forward.”

1 These are non-GAAP financial measures. A reconciliation of GAAP to non-GAAP financial measures has been provided in the financial tables included in this press release. An explanation of these measures and how they are calculated are also included below under the heading “Supplemental Information – Non-GAAP Financial Measures”.

Fleet Operating Data 

    Three Months Ended   Six Months Ended
    June 30, 2021   June 30, 2020   June 30, 2021   June 30, 2020
Ownership Days   4,511     4,550     8,710     9,100  
Chartered in Days   497     525     1,155     1,129  
Available Days   4,824     5,007     9,472     9,878  
Operating Days   4,778     4,962     9,400     9,793  
Fleet Utilization (%)   99.0 %   99.1 %   99.2 %   99.1 %
                         

Fleet Development

Vessels acquired and delivered into the fleet in the second quarter of 2021

  • Sankaty Eagle, a Supramax (58K DWT / 2011-built)
  • Montauk Eagle, a Supramax (58K DWT / 2011-built)
  • Rotterdam Eagle, an Ultramax (64K DWT / 2017-built)

Vessels acquired and expected to be delivered in the third quarter of 2021

  • Newport Eagle, a Supramax (58K DWT / 2011-built)
  • Antwerp Eagle, an Ultramax (64K DWT / 2015-built)
  • Valencia Eagle, an Ultramax (64K DWT / 2015-built)

Vessels sold and expected to be delivered in the third quarter of 2021

  • Tern, a Supramax (50K DWT / 2003-built) for net proceeds of 
    $9.7 million

Effective as of 
September 15, 2020, the Company completed a 1-for-7 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding shares of common stock, par value 
$0.01 per share, as previously approved by our Board of Directors (the “Board of Directors”) and our shareholders. Proportional adjustments were made to the Company’s issued and outstanding common stock and to the exercise price and the number of shares issuable upon exercise of all of the Company’s outstanding warrants, the exercise price and number of shares issuable upon exercise of the options outstanding under the Company’s equity incentive plans, and the number of shares subject to restricted stock awards under the Company’s equity incentive plans. All references to common stock and all per share data relating to periods prior to the Reverse Stock Split that are contained in this press release for the three and six months ended 
June 30, 2021 have been retrospectively adjusted to reflect the Reverse Stock Split unless explicitly stated otherwise.

Results of Operations for the three and six months ended June 30, 2021 and 2020

For the three months ended 
June 30, 2021, the Company reported net income of 
$9.2 million, or basic and diluted income of 
$0.76 per share and 
$0.74 per share, respectively. In the comparable quarter of 2020, the Company reported a net loss of 
$20.5 million, or basic and diluted loss of 
$1.99 per share.

For the three months ended 
June 30, 2021, the Company reported an adjusted net income of 
$40.3 million, which excludes the unrealized loss on derivative instruments of 
$31.0 million or basic and diluted adjusted income of 
$3.31 per share and 
$2.63 per share, respectively.

For the six months ended 
June 30, 2021, the Company reported net income of 
$19.1 million, or basic and diluted income of 
$1.60 per share and 
$1.58 per share, respectively. In the comparable period of 2020, the Company reported a net loss of 
$24.0 million, or basic and diluted loss of 
$2.34 per share.

For the six months ended 
June 30, 2021, the Company reported an adjusted net income of 
$49.6 million, which excludes the unrealized loss on derivative instruments of 
$30.5 million or basic and diluted adjusted income of 
$4.15 per share and 
$3.31 per share, respectively.

Revenues, net

Net time and voyage charter revenues for the three months ended 
June 30, 2021 were 
$129.9 million compared with 
$57.4 million recorded in the comparable quarter in 2020. The increase in revenues was primarily attributable to higher charter rates as a result of the market recovery with increase in demand for drybulk products offset by a decrease in available days due to fewer owned days.

Net time and voyage charter revenues for the six months ended 
June 30, 2021 and 2020 were 
$226.4 million and 
$131.8 million, respectively. The increase in revenues was primarily due to higher charter rates offset by a decrease in available days due to fewer owned days.

Voyage expenses

Voyage expenses for the three months ended 
June 30, 2021 and 2020 were 
$24.5 million compared to 
$23.8 million in the comparable quarter in 2020. The increase in voyage expenses was primarily due to an increase in broker commission expense as a result of the increase in revenues.

Voyage expenses for the six months ended 
June 30, 2021 were 
$51.1 million compared to 
$50.3 million in the comparable period in 2020. The increase in voyage expenses was primarily due to an increase in bunker consumption expense as bunker fuel prices increased in the current year compared to prior year and an increase in broker commission expense as a result of the increase in Revenues.

Vessel operating expenses

Vessel operating expenses for the three months ended 
June 30, 2021 were 
$23.7 million compared to 
$20.2 million in the comparable quarter in 2020. The increase in vessel operating expenses was primarily attributable to increases in lubes expense as a result of an increase in prices as well as higher inventory levels and vessel start-up expenses as the Company purchased three vessels in the second quarter of 2021. The Company continues to incur higher costs related to crew changes due to the ongoing COVID-19 pandemic. The ownership days for the three months ended 
June 30, 2021 and 2020 were 4,511 and 4,550, respectively.

Average daily vessel operating expenses excluding one-time, non-recurring expenses related to vessel acquisitions and sales for the three months ended 
June 30, 2021 was 
$5,020 as compared to 
$4,447 for the three months ended 
June 30, 2020.

Vessel operating expenses for the six months ended 
June 30, 2021 were 
$45.2 million compared to 
$43.9 million in the comparable period in 2020. The increase in vessel expenses was primarily attributable to an increase in lubes expense as a result of an increase in prices as well as higher inventory levels and vessel start-up expenses as the Company purchased six vessels in the first half of 2021, offset by a decrease in ownership days. The ownership days for the six months ended 
June 30, 2021 and 2020 were 8,710 and 9,100, respectively.

Average daily vessel operating expenses excluding one-time, non-recurring expenses related to vessel acquisitions and sales for the six months ended 
June 30, 2021 was 
$4,959 as compared to 
$4,828 for the six months ended 
June 30, 2020.

Charter hire expenses

Charter hire expenses for the three months ended 
June 30, 2021 were 
$6.2 million compared to 
$4.7 million in the comparable quarter in 2020. The increase in charter hire expenses was principally due to an increase in charter hire rates due to improvement in the charter hire market, offset by a marginal decrease in chartered-in days. The total chartered-in days for the three months ended 
June 30, 2021 were 497 compared to 525 for the comparable quarter in the prior year. The Company currently charters in three Ultramax vessels on a long term basis with remaining lease terms of approximately one year.

Charter hire expenses for the six months ended 
June 30, 2021 were 
$14.6 million compared to 
$10.8 million in the comparable period in 2020. The increase in charter hire expenses was primarily due to an increase in charter hire rates due to improvement in the charter hire market and an increase in the number of chartered-in days. The total chartered-in days for the six months ended 
June 30, 2021 were 1,155 compared to 1,129 for the comparable period in the prior year.

Depreciation and amortization

Depreciation and amortization expense for the three months ended 
June 30, 2021 and 2020 was 
$13.1 million and 
$12.5 million, respectively. Total depreciation and amortization expense for the three months ended 
June 30, 2021 includes 
$11.0 million of vessel and other fixed asset depreciation and 
$2.1 million relating to the amortization of deferred drydocking costs. Comparable amounts for the three months ended 
June 30, 2020 were 
$10.7 million of vessel and other fixed asset depreciation and 
$1.8 million of amortization of deferred drydocking costs.

Depreciation and amortization expense for the six months ended 
June 30, 2021 and 2020 was 
$25.6 million and 
$25.0 million, respectively. Total depreciation and amortization expense for the six months ended 
June 30, 2021 includes 
$21.5 million of vessel and other fixed asset depreciation and 
$4.1 million relating to the amortization of deferred drydocking costs. Comparable amounts for the six months ended 
June 30, 2020 were 
$21.3 million of vessel and other fixed asset depreciation and 
$3.7 million of amortization of deferred drydocking costs.

General and administrative expenses

General and administrative expenses for the three months ended 
June 30, 2021 and 2020 were 
$7.9 million and 
$6.8 million, respectively. General and administrative expenses included stock-based compensation of 
$0.6 million and 
$0.7 million for the three months ended 
June 30, 2021 and 2020, respectively.

General and administrative expenses for the six months ended 
June 30, 2021 and 2020 were 
$15.6 million and 
$14.7 million, respectively. General and administrative expenses included stock-based compensation of 
$1.5 million and 
$1.6 million for the six months ended 
June 30, 2021 and 2020, respectively.

Other operating expense

Other operating expense for the three and six months ended 
June 30, 2021 was 
$0.6 million and 
$1.5 million, respectively. In 
March 2021, the 
U.S. government began investigating an allegation that one of our vessels may have improperly disposed of ballast water that entered the engine room bilges during a repair. The Company posted a surety bond as security for any fines and penalties. Other operating expense consists of expenses relating to the incident, which include legal fees, surety bond expenses, vessel offhire, crew changes and travel costs.

Interest expense

Interest expense for the three months ended 
June 30, 2021 and 2020 was 
$8.8 million and 
$8.7 million, respectively.

Interest expense for the six months ended 
June 30, 2021 and 2020 was 
$17.1 million and 
$17.9 million, respectively. The decrease in interest expense was primarily due to a decrease in outstanding debt under the Norwegian Bond Debt and a decrease in interest rates on the New Ultraco Debt Facility.

Realized and unrealized loss/(gain) on derivative instruments, net

Realized and unrealized loss/(gain) on derivative instruments, net for the three months ended 
June 30, 2021 and 2020 was 
$35.9 million and 
$0.9 million, respectively. The increase in realized and unrealized losses on derivative instruments was primarily due to the sharp increase in charter hire rates. The non cash unrealized losses on forward freight agreements (“FFA”) related to the second half of 2021 and 2022 amounted to 
$31.8 million based on 2,430 days hedged at an weighted average FFA contract price of 
$15,988 per day.

Realized and unrealized loss on derivative instruments, net for the six months ended 
June 30, 2021 was 
$36.6 million compared to a realized and unrealized gain on derivative instruments, net of 
$7.0 million for the six months ended 
June 30, 2020. The increase in realized and unrealized losses on derivative instruments was primarily due to the sharp increase in charter hire rates.

Liquidity and Capital Resources

  Six Months Ended
  June 30, 2021   June 30, 2020
Net cash provided by/(used in) operating activities (1) $ 30,585,379     $ (15,173,185 )
Net cash used in investing activities (2) (86,503,299 )   (19,263,564 )
Net cash provided by financing activities (3) 50,868,477     73,913,522  
Net (decrease)/increase in cash, cash equivalents and restricted cash (5,049,443 )   39,476,773   
Cash, cash equivalents and restricted cash at beginning of period 88,848,771     59,130,285  
Cash, cash equivalents and restricted cash at end of period $ 83,799,328     $ 98,607,058  
               

(1) Net cash provided by operating activities for the six months ended 
June 30, 2021 was 
$30.6 million, compared with net cash used in operating activities of 
$15.2 million in the comparable period in 2020. The cash flows from operating activities increased as compared to the same period in the prior year primarily due to the increase in charter hire rates.

(2) Net cash used in investing activities for the six months ended 
June 30, 2021 was 
$86.5 million, compared to 
$19.3 million in the comparable period in the prior year. During the six months ended 
June 30, 2021, the Company purchased six vessels for 
$77.8 million and paid 
$5.3 million as advances for the purchase of three additional vessels to be delivered in the third quarter of 2021. The Company paid 
$2.4 million for the purchase of ballast water treatment systems on our fleet. The Company also received insurance proceeds of 
$0.2 million for hull and machinery claims. Additionally, the Company paid 
$1.2 million for vessel improvements.

(3) Net cash provided by financing activities for the six months ended 
June 30, 2021 was 
$50.9 million compared to 
$73.9 million in the comparable period in 2020. During the six months ended 
June 30, 2021, the Company received 
$55.0 million in proceeds from the revolver loan under the New Ultraco Debt Facility, 
$11.0 million in proceeds from the term loan under the New Ultraco Debt Facility, 
$24.0 million in proceeds from the Holdco Revolving Credit Facility and 
$27.4 million in net proceeds from the ATM offering. The Company repaid 
$15.9 million of the New Ultraco Debt Facility, 
$4.0 million of the Norwegian Bond Debt, 
$30.0 million of the revolver loan under the New Ultraco Debt Facility and 
$15.0 million of the revolver loan under the Super Senior Facility. The Company also paid 
$1.0 million to settle net share equity awards. Additionally, the Company paid 
$0.2 million to the lenders of the Holdco Revolving Credit Facility, 
$0.2 million to the lenders of the New Ultraco Debt Facility and 
$0.3 million in financing costs relating to the equity offerings in 
December 2020.

As of 
June 30, 2021, our cash and cash equivalents including restricted cash was 
$83.8 million compared to 
$88.8 million as of 
December 31, 2020.

As of 
June 30, 2021, the Company’s debt consisted of 
$176.0 million in outstanding bonds under the Norwegian Bond Debt, 
$186.5 million under the New Ultraco Debt Facility, which includes 
$25.0 million of an outstanding revolver loan, 
$24.0 million under the Holdco Revolving Credit Facility and the Convertible Bond Debt of 
$114.1 million.

In addition, as of 
June 30, 2021, we had 
$56.0 million in undrawn revolver facilities available under the New Ultraco Debt Facility, Super Senior Facility and the Holdco Revolving Credit Facility.

Capital Expenditures and Drydocking

Our capital expenditures relate to the purchase of vessels and capital improvements to our vessels, which are expected to enhance the revenue earning capabilities and safety of the vessels.

In addition to acquisitions that we may undertake in future periods, the Company’s other major capital expenditures include funding the Company’s program of regularly scheduled drydocking necessary to comply with international shipping standards and environmental laws and regulations. Although the Company has some flexibility regarding the timing of its drydocking, the costs are relatively predictable. Management anticipates that vessels are to be drydocked every two and a half years for vessels older than 15 years and five years for vessels younger than 15 years. Funding of these requirements is anticipated to be met with cash from operations. We anticipate that this process of recertification will require us to reposition these vessels from a discharge port to shipyard facilities, which will reduce our available days and operating days during that period.

Drydocking costs incurred are deferred and amortized to expense on a straight-line basis over the period through the date of the next scheduled drydocking for those vessels. In the six months ended 
June 30, 2021, four of our vessels completed drydock one of our vessels was still in drydock as of 
June 30, 2021, and we incurred drydocking expenditures of 
$6.4 million. In the six months ended 
June 30, 2020, four of our vessels completed drydock and we incurred drydocking expenditures of 
$6.6 million.

The following table represents certain information about the estimated costs for anticipated vessel drydockings, BWTS, and vessel upgrades in the next four quarters, along with the anticipated off-hire days:

    Projected Costs (1) (in millions)
Quarter Ending Off-hire Days(2) BWTS Drydocks Vessel Upgrades(3)
September 30, 2021 283   $ 3.0   $ 6.6   $ 1.2  
December 31, 2021 278   2.6   5.3   1.0  
March 31, 2022 152   1.8   1.4   0.4  
June 30, 2022 118   0.3   1.2   0.4  

(1) Actual costs will vary based on various factors, including where the drydockings are actually performed.
(2) Actual duration of off-hire days will vary based on the age and condition of the vessel, yard schedules and other factors.
(3) Vessel upgrades represents capex relating to items such as high-spec low friction hull paint which improves fuel efficiency and reduces fuel costs, 
NeoPanama Canal chock fittings enabling vessels to carry additional cargo through the new 
Panama Canal locks, as well as other retrofitted fuel-saving devices. Vessel upgrades are discretionary in nature and evaluated on a business case-by-case basis.

SUMMARY CONSOLIDATED FINANCIAL AND OTHER DATA

The following table summarizes the Company’s selected condensed consolidated financial and other data for the periods indicated below.

 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

  Three Months Ended   Six Months Ended
  June 30, 2021   June 30, 2020   June 30, 2021   June 30, 2020
Revenues, net $ 129,850,586     $ 57,391,784     $ 226,422,754     $ 131,770,103  
               
Voyage expenses 24,522,734     23,767,747     51,137,653     50,332,105  
Vessel operating expenses 23,679,665     20,232,274     45,198,104     43,932,383  
Charter hire expenses 6,169,544     4,719,367     14,649,764     10,760,306  
Depreciation and amortization 13,110,597     12,503,191     25,616,983     24,969,674  
General and administrative expenses 7,912,970     6,767,403     15,611,180     14,728,475  
Other operating expense 559,128         1,520,244      
Operating lease impairment     352,368         352,368  
Total operating expenses 75,954,638     68,342,350     153,733,928     145,075,311  
Operating income/(loss) 53,895,948     (10,950,566 )   72,688,826     (13,305,208 )
Interest expense 8,799,137     8,737,079     17,050,558     17,928,894  
Interest income (15,529 )   (56,132 )   (33,298 )   (212,989 )
Realized and unrealized loss/(gain) on derivative instruments, net 35,887,315     859,814     36,597,231     (7,002,027 )
Total other expense, net 44,670,923     9,540,761     53,614,491     10,713,878  
Net income/(loss) $ 9,225,025     $ (20,491,327 )   $ 19,074,335     $ (24,019,086 )
               
Weighted average shares outstanding*:              
Basic* 12,168,180     10,277,946     11,950,048     10,272,484  
Diluted* 12,397,156     10,277,946     12,081,772     10,272,484  
               
Per share amounts*:              
Basic income/(loss)* $ 0.76     $ (1.99 )   $ 1.60     $ (2.34 )
Diluted income/(loss)* $ 0.74     $ (1.99 )   $ 1.58     $ (2.34 )
                               

* Adjusted to give effect for the 1-for-7 Reverse Stock Split that became effective as of 
September 15, 2020.

CONDENSED CONSOLIDATED BALANCE SHEETS

  June 30, 2021   December 31, 2020
ASSETS:      
Current assets:      
Cash and cash equivalents $ 79,278,151     $ 69,927,594  
Restricted cash – current 4,446,177     18,846,177  
Accounts receivable, net of a reserve of 
$2,134,000 and 
$2,357,191, respectively
23,995,321     13,843,480  
Prepaid expenses 4,294,715     3,182,815  
Inventories 15,899,222     11,624,833  
Vessel held for sale 4,885,998      
Collateral on derivatives 33,499,170      
Other current assets 1,478,163     839,881  
Total current assets 167,776,917     118,264,780  
Noncurrent assets:      
Vessels and vessel improvements, at cost, net of accumulated depreciation of 
$195,472,078 and 
$177,771,755, respectively
876,088,651     810,713,959  
Advances for vessel purchases 5,340,000     3,250,000  
Operating lease right-of-use assets 12,441,041     7,540,871  
Other fixed assets, net of accumulated depreciation of 
$1,276,574 and 
$1,137,562, respectively
363,993     489,179  
Restricted cash – noncurrent 75,000     75,000  
Deferred drydock costs, net 26,504,065     24,153,776  
Deferred financing costs 99,033      
Fair value of derivatives asset – noncurrent 36,384      
Advances for ballast water systems and other assets 4,443,281     2,639,491  
Total noncurrent assets 925,391,448     848,862,276  
Total assets $ 1,093,168,365     $ 967,127,056  
LIABILITIES & STOCKHOLDERS’ EQUITY      
Current liabilities:      
Accounts payable $ 18,921,097     $ 10,589,970  
Accrued interest 4,558,933     4,690,135  
Other accrued liabilities 10,601,676     11,747,064  
Fair value of derivatives – current 31,607,854     481,791  
Current portion of operating lease liabilities 11,639,630     7,615,371  
Unearned charter hire revenue 8,402,876     8,072,295  
Holdco Revolving Credit Facility, net of debt issuance costs 23,724,982      
Current portion of long-term debt 41,444,297     39,244,297  
Total current liabilities 150,901,345     82,440,923  
Noncurrent liabilities:      
Norwegian Bond Debt, net of debt discount and debt issuance costs 165,993,915     169,290,230  
Super Senior Facility, net of debt issuance costs     14,896,357  
New Ultraco Debt Facility, net of debt issuance costs 125,093,090     132,083,949  
Revolver loan under the New Ultraco Debt Facility 25,000,000      
Convertible Bond Debt, net of debt discount and debt issuance costs 98,736,604     96,660,485  
Fair value of derivatives – noncurrent 85,603     650,607  
Noncurrent portion of operating lease liabilities 1,099,452     686,422  
Total noncurrent liabilities 416,008,664     414,268,050  
Total liabilities 566,910,009     496,708,973  
Commitments and contingencies      
Stockholders’ equity:      
Preferred stock, 
$.01 par value, 25,000,000 shares authorized, none issued as of 
June 30, 2021 and 
December 31, 2020
     
Common stock, 
$0.01 par value, 700,000,000 shares authorized, 12,753,255 and 11,661,797 shares issued and outstanding as of 
June 30, 2021 and 
December 31, 2020, respectively
127,533     116,618  
Additional paid-in capital 979,682,504     943,571,685  
Accumulated deficit (453,063,487 )   (472,137,822 )
Accumulated other comprehensive loss (488,194 )   (1,132,398 )
Total stockholders’ equity 526,258,356     470,418,083  
Total liabilities and stockholders’ equity $ 1,093,168,365     $ 967,127,056  
               

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

  Six Months Ended
  June 30, 2021   June 30, 2020
Cash flows from operating activities:      
Net income/(loss) $ 19,074,335     $ (24,019,086 )
Adjustments to reconcile net income/(loss) to net cash provided by/(used in) operating activities:      
Depreciation 21,537,938     21,303,889  
Amortization of operating lease right-of-use assets 6,201,490     6,273,102  
Amortization of deferred drydocking costs 4,079,045     3,665,785  
Amortization of debt discount and debt issuance costs 3,467,185     3,046,071  
Operating lease impairment     352,368  
Net unrealized loss on fair value of derivatives 30,540,919     814,014  
Stock-based compensation expense 1,457,811     1,559,423  
Drydocking expenditures (6,429,334 )   (6,576,633 )
Changes in operating assets and liabilities:      
Accounts payable 8,216,287     (4,523,437 )
Accounts receivable (10,390,156 )   (2,921,947 )
Accrued interest (131,202 )   (306,303 )
Inventories (4,274,389 )   5,719,516  
Operating lease liabilities current and noncurrent (6,664,371 )   (6,603,999 )
Collateral on derivatives (33,499,170 )    
Other current and noncurrent assets (40,507 )   (7,078,072 )
Other accrued liabilities (1,779,183 )   (7,280,400 )
Prepaid expenses (1,111,900 )   1,214,764  
Unearned charter hire revenue 330,581     187,760  
Net cash provided by/(used in) operating activities 30,585,379     (15,173,185 )
       
Cash flows from investing activities:      
Purchase of vessels and vessel improvements (79,002,764 )   (510,029 )
Advances for vessel purchases (5,340,000 )    
Purchase of scrubbers and ballast water systems (2,385,024 )   (22,371,606 )
Proceeds from hull and machinery insurance claims 238,315     3,658,924  
Purchase of other fixed assets (13,826 )   (40,853 )
Net cash used in investing activities (86,503,299 )   (19,263,564 )
       
Cash flows from financing activities:      
Proceeds from New Ultraco Debt Facility 11,000,000     22,550,000  
Repayment of Norwegian Bond Debt (4,000,000 )   (4,000,000 )
Repayment of term loan under New Ultraco Debt Facility (15,897,148 )   (13,112,245 )
Repayment of revolver loan under New Ultraco Debt Facility (30,000,000 )    
Repayment of revolver loan under Super Senior Facility (15,000,000 )    
Proceeds from revolver loan under New Ultraco Debt Facility 55,000,000     55,000,000  
Proceeds from revolver loan under Super Senior Facility     15,000,000  
Proceeds from Holdco Revolving Credit Facility 24,000,000      
Proceeds from issuance of shares under ATM Offering, net of commissions 27,372,417      
Cash received from exercise of stock options 22,224      
Cash used to settle net share equity awards (985,686 )   (1,161,301 )
Equity offerings issuance costs (291,830 )    
Debt issuance costs paid to lenders on New Ultraco Debt Facility (181,500 )   (381,471 )
Debt issuance costs paid to lenders of Holdco Revolving Credit Facility (170,000 )    
Other financing costs     18,539  
Net cash provided by financing activities 50,868,477     73,913,522  
       
Net (decrease)/increase in Cash, cash equivalents and Restricted cash (5,049,443 )   39,476,773  
Cash, cash equivalents and restricted cash at beginning of period 88,848,771     59,130,285  
Cash, cash equivalents and restricted cash at end of period $ 83,799,328     $ 98,607,058  
SUPPLEMENTAL CASH FLOW INFORMATION      
Cash paid during the period for interest $ 13,419,869     $ 15,202,876  
Accruals for vessel purchases and vessel improvements included in Other accrued liabilities $ 229,185     $  
Accruals for scrubbers and ballast water treatment systems included in Accounts payable and Other accrued liabilities $ 3,345,643     $ 8,507,683  
Accrual for issuance costs for ATM Offering included in Other accrued liabilities $ 88,500     $  
Accruals for debt issuance costs included in Other accrued liabilities $ 500,000     $ 200,000  
               

Supplemental Information – Non-GAAP Financial Measures

This release includes various financial measures that are non-GAAP financial measures as defined under the rules of the 
Securities and Exchange Commission (SEC). We believe these measures provide important supplemental information to investors to use in evaluating ongoing operating results. We use these measures, together with GAAP measures, for internal managerial purposes and as a means to evaluate period-to-period comparisons. These non-GAAP financial measures are also used as supplemental financial measures by external users of our financial statements, such as investors, commercial banks and others, to assess our operating performance as compared to that of other companies in our industry. However, we do not, and you should not, rely on non-GAAP financial measures alone as measures of our performance, and these non-GAAP financial measures should not be considered an alternative to other measures of financial performance or liquidity presented in accordance with GAAP. Additionally, because non-GAAP financial measures are not standardized, these non-GAAP financial measures may not be comparable to similarly titled measures of another company. Nonetheless, we believe that non-GAAP financial measures reflect an additional way of viewing aspects of our operations that when taken together with GAAP results and the reconciliations to corresponding GAAP financial measures that we also provide in our press releases provide a more complete understanding of factors and trends affecting our business. We strongly encourage you to review all of our financial statements and publicly-filed reports in their entirety and to not rely on any single financial measure.

Non-GAAP Financial Measures

(1) Adjusted net income/(loss) and Adjusted Basic and Diluted income/(loss) per share

Adjusted net income/(loss) and Adjusted Basic and Diluted income/(loss) per share represents Net income and Basic and Diluted income/(loss) per share, respectively, as adjusted to exclude non-cash unrealized losses/(gains) on derivatives. The Company utilizes derivative instruments such as FFAs to partially hedge against its underlying long physical position in ships (as represented by owned and third-party chartered-in vessels). The Company does not apply hedge accounting, and, as such, the mark-to-market gains/(losses) on forward hedge positions impact current quarter results, causing timing mismatches in the Statement of Operations. We believe that Adjusted net income/(loss) and Adjusted income/(loss) per share are more useful to analysts and investors in comparing the results of operations and operational trends between periods and relative to other peer companies in our industry. Our Adjusted net income/(loss) should not be considered an alternative to net income/(loss), operating income/(loss), cash flows provided by/(used in) by operating activities or any other measure of financial performance or liquidity presented in accordance with 
U.S. GAAP. As noted above, our Adjusted net income/(loss) may not be comparable to similarly titled measures of another company because all companies may not calculate Adjusted net income/(loss) in the same manner.

The following table presents the reconciliation of our Net income/(loss) to Adjusted net income/(loss):

Reconciliation of GAAP Net income/(loss) to Adjusted Net income/(loss)

    Three Months Ended   Six Months Ended
    June 30, 2021   June 30, 2020   June 30, 2021   June 30, 2020
Net income/(loss)   $ 9,225,025     $ (20,491,327 )   $ 19,074,335     $ (24,019,086 )
Adjustments to reconcile net income/(loss) to Adjusted net income/(loss):                
Unrealized loss on derivatives   31,044,154     8,023,888     30,540,919     918,017  
Adjusted Net income/(loss)   $ 40,269,179     $ (12,467,439 )   $ 49,615,254     $ (23,101,069 )
                 
Weighted average shares outstanding(1):                
Basic (1)   12,168,180     10,277,946     11,950,048     10,272,484  
Diluted (1) (2)   15,303,191     10,277,946     14,987,807     10,272,484  
                 
Per share amounts(1):                
Basic adjusted net income/(loss)(1)   $ 3.31     $ (1.21 )   $ 4.15     $ (2.25 )
Diluted adjusted net income/(loss)(1) (2)   $ 2.63     $ (1.21 )   $ 3.31     $ (2.25 )
                                 

(1) Adjusted to give effect for the 1-for-7 Reverse Stock Split that became effective as of 
September 15, 2020.
(2) The number of shares used in the Diluted adjusted net income per share calculation for the three and six months ended 
June 30, 2021 includes 2,906,035 dilutive shares related to the Convertible Bond Debt based on If-converted method per US GAAP.

(2) EBITDA and Adjusted EBITDA

We define EBITDA as net income under GAAP adjusted for interest, income taxes, depreciation and amortization.

Our Adjusted EBITDA should not be considered an alternative to net income/(loss), operating income/(loss), cash flows provided by/(used in) by operating activities or any other measure of financial performance or liquidity presented in accordance with GAAP. Our Adjusted EBITDA may not be comparable to similarly titled measures of another company because all companies may not calculate Adjusted EBITDA in the same manner.

Beginning this quarter and retroactively adjusted for prior periods, Adjusted EBITDA also now excludes non cash unrealized gains and losses on derivative instruments. We believe that the change better reflects the operational cash flows generated within the respective reporting period .

Adjusted EBITDA represents EBITDA adjusted to exclude the items which represent certain non-cash, one-time and other items such as vessel impairment, unrealized loss/(gains) on derivative instruments, operating lease impairment, (gain)/loss on sale of vessels, loss on debt extinguishment and stock-based compensation expense that the Company believes are not indicative of the ongoing performance of its core operations. The following table presents a reconciliation of our net income/(loss) to EBITDA and Adjusted EBITDA.

Reconciliation of GAAP Net income/(loss) to EBITDA and Adjusted EBITDA

    Three Months Ended   Six Months Ended
    June 30, 2021   June 30, 2020   June 30, 2021   June 30, 2020
Net income/(loss)   $ 9,225,025     $ (20,491,327 )   $ 19,074,335     $ (24,019,086 )
Adjustments to reconcile net income/(loss) to EBITDA:                
Interest expense   8,799,137     8,737,079     17,050,558     17,928,894  
Interest income   (15,529 )   (56,132 )   (33,298 )   (212,989 )
Income taxes                
EBIT   18,008,633     (11,810,380 )   36,091,595     (6,303,181 )
Depreciation and amortization   13,110,597     12,503,191     25,616,983     24,969,674  
EBITDA   31,119,230     692,811     61,708,578     18,666,493  
Non-cash, one-time and other adjustments to EBITDA(1)   31,630,022     9,099,479     31,998,730     2,829,808  
Adjusted EBITDA   $ 62,749,252     $ 9,792,290     $ 93,707,308     $ 21,496,301  
                                 

(1) One-time and other adjustments to EBITDA for the three and six months ended 
June 30, 2021 includes stock-based compensation and unrealized losses on derivatives. One-time and other adjustments to EBITDA for the three and six months ended 
June 30, 2020 includes stock-based compensation, unrealized losses on derivatives and an operating lease impairment.

TCE revenue and TCE

Time charter equivalent (“TCE”) is a non-GAAP financial measure that is commonly used in the shipping industry primarily to compare daily earnings generated by vessels on time charters with daily earnings generated by vessels on voyage charters, because charter hire rates for vessels on voyage charters are generally not expressed in per-day amounts while charter hire rates for vessels on time charters generally are expressed in such amounts. The Company defines TCE as shipping revenues less voyage expenses and charter hire expenses, adjusted for the impact of one legacy time charter and realized gains/(losses) on FFAs and bunker swaps, divided by the number of owned available days. TCE provides additional meaningful information in conjunction with shipping revenues, the most directly comparable GAAP measure, because it assists Company management in making decisions regarding the deployment and use of its vessels and in evaluating their financial performance. The Company’s calculation of TCE may not be comparable to that reported by other companies. The Company calculates relative performance by comparing TCE against the Baltic Supramax Index (“BSI”) adjusted for commissions and fleet makeup. Owned available days is the number of our ownership days less the aggregate number of days that our vessels are off-hire due to vessel familiarization upon acquisition, repairs, vessel upgrades or special surveys. The shipping industry uses available days to measure the number of days in a period during which vessels should be capable of generating revenues.

The following table presents the reconciliation of revenues, net to TCE:

Reconciliation of Revenues, net to TCE

  Three Months Ended   Six Months Ended
  June 30, 2021   June 30, 2020   June 30, 2021   June 30, 2020
Revenues, net $ 129,850,586     $ 57,391,784     $ 226,422,754     $ 131,770,103  
Less:              
Voyage expenses $ (24,522,734 )   $ (23,767,747 )   $ (51,137,653 )   $ (50,332,105 )
Charter hire expenses $ (6,169,544 )   $ (4,719,367 )   $ (14,649,764 )   $ (10,760,306 )
Reversal of one legacy time charter $ (936,977 )   $ (41,880 )   $ (854,156 )   $ 420,756  
Realized (loss)/gain on FFAs and bunker swaps $ (4,843,161 )   $ 7,164,074     $ (6,056,312 )   $ 7,920,043  
TCE revenue $ 93,378,170     $ 36,026,864     $ 153,724,869     $ 79,018,491  
               
Owned available days $ 4,327     $ 4,482     $ 8,317     $ 8,749  
TCE $ 21,580     $ 8,038     $ 18,483     $ 9,032  
                               

Glossary of Terms:

Ownership days: We define ownership days as the aggregate number of days in a period during which each vessel in our fleet has been owned by us. Ownership days are an indicator of the size of our fleet over a period and affect both the amount of revenues and the amount of expenses that we recorded during a period.

Chartered-in under operating lease days: We define chartered-in under operating lease days as the aggregate number of days in a period during which we chartered-in vessels. Periodically, the Company charters in vessels on a single trip basis.

Available days: We define available days as the number of our ownership days and chartered-in days less the aggregate number of days that our vessels are off-hire due to vessel familiarization upon acquisition, repairs, vessel upgrades or special surveys and other reasons which prevent the vessel from performing under the relevant charter party such as surveys, medical events, stowaway disembarkation, etc. The shipping industry uses available days to measure the number of days in a period during which vessels should be capable of generating revenues.

Operating days: We define operating days as the number of available days in a period less the aggregate number of days that our vessels are off-hire due to any reason, including unforeseen circumstances. The shipping industry uses operating days to measure the aggregate number of days in a period during which vessels actually generate revenues.

Fleet utilization: We calculate fleet utilization by dividing the number of our operating days during a period by the number of our available days during the period. The shipping industry uses fleet utilization to measure a company’s efficiency in finding suitable employment for its vessels and minimizing the amount of days that its vessels are off-hire for reasons other than scheduled repairs or repairs under guarantee, vessel upgrades, special surveys or vessel positioning. Our fleet continues to perform at high utilization rates.

Definitions of capitalized terms related to our Indebtedness

Norwegian Bond Debt: Norwegian Bond Debt refers to the Senior Secured Bonds issued by 
Eagle Bulk Shipco LLC, a wholly-owned subsidiary of the Company (“Shipco”), as borrower, certain wholly-owned vessel-owning subsidiaries of Shipco, as guarantors (“Shipco Vessels”), on 
November 28, 2017 for 
$200.0 million, pursuant to those certain Bond Terms, dated as of 
November 22, 2017, by and between Shipco, as issuer, and 
Nordic Trustee AS, a company existing under the laws of 
Norway (the “Bond Trustee”). The bonds, currently at 
$176.0 million, are secured by 20 vessels and restricted cash.

New Ultraco Debt Facility: New Ultraco Debt Facility refers to senior secured credit facility for 
$208.4 million entered into by 
Ultraco Shipping LLC (“Ultraco”), a wholly-owned subsidiary of the Company, as the borrower (the “New Ultraco Debt Facility”), with the Company and certain of its indirectly vessel-owning subsidiaries, as guarantors (the “Guarantors”), the lenders party thereto, the swap banks party thereto, 
ABN AMRO Capital USA LLC (“ABN AMRO”), 
Credit Agricole Corporate and Investment Bank, Skandinaviska Enskilda Banken AB (PUBL) and 
DNB Markets Inc., as mandated lead arrangers and bookrunners, and 
Credit Agricole Corporate and Investment Bank, as arranger, security trustee and facility agent. The New Ultraco Debt Facility provides for an aggregate principal amount of 
$208.4 million, which consists of (i) a term loan facility of 
$153.4 million and (ii) a revolving credit facility of 
$55.0 million. As of 
June 30, 2021
$30.0 million of the revolving credit facility remains undrawn. The New Ultraco Debt Facility is secured by 28 vessels.

Convertible Bond Debt: Convertible Bond Debt refers to 
$114.1 million that the Company raised from its issuance of 5.0% Convertible Senior Notes on 
July 29, 2019. They are due in 2024.

Super Senior Facility: Super Senior Facility refers to the credit facility for 
$15.0 million, by and among Shipco as borrower, and 
ABN AMRO Capital USA LLC, as original lender, mandated lead arranger and agent. As of 
June 30, 2021
$15.0 million of the revolving credit facility remains undrawn.

Holdco Revolving Credit Facility: Holdco Revolving Credit Facility refers to the senior secured revolving credit facility for 
$35.0 million, by and among 
Eagle Bulk Holdco LLC (“Holdco”), a wholly-owned subsidiary of the Company, as borrower, and Crédit 
Agricole Corporate and Investment Bank, as lender, facility agent, security trustee and mandated lead arranger with Nordea Bank ABP, 
New York Branch. The Holdco Revolving Credit Facility is secured by three vessels. As of 
June 30, 2021
$11.0 million of the revolving credit facility remains undrawn.

Conference Call Information

As previously announced, members of Eagle Bulk’s senior management team will host a teleconference and webcast at 
8:00 a.m. ET on 
Friday, August 6, 2021, to discuss the second quarter results.

To participate in the teleconference, investors and analysts are invited to call 1 844-282-4411 in the 
U.S., or 1 512-900-2336 outside of the 
U.S., and reference participant code 3636539. A simultaneous webcast of the call, including a slide presentation for interested investors and others, may be accessed by visiting http://www.eagleships.com.

A replay will be available following the call from 
11:00 AM ET on 
August 6, 2021 until 
11:00 AM ET on 
August 16, 2021. To access the replay, call +1 855-859-2056 in the 
U.S., or +1 404-537-3406 outside of the 
U.S., and reference passcode 3636539.

About Eagle Bulk Shipping Inc.

Eagle Bulk Shipping Inc. (“Eagle” or the “Company”) is a 
U.S. based fully integrated shipowner-operator providing global transportation solutions to a diverse group of customers including miners, producers, traders, and end users. Headquartered in 
Stamford, Connecticut, with offices in 
Singapore and 
Copenhagen, Denmark, Eagle focuses exclusively on the versatile mid-size drybulk vessel segment and owns one of the largest fleets of Supramax/Ultramax vessels in the world. The Company performs all management services in-house (including: strategic, commercial, operational, technical, and administrative) and employs an active management approach to fleet trading with the objective of optimizing revenue performance and maximizing earnings on a risk-managed basis. For further information, please visit our website: www.eagleships.com.

Website Information 

We intend to use our website, www.eagleships.com, as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included in our website’s Investor Relations section. Accordingly, investors should monitor the Investor Relations portion of our website, in addition to following our press releases, filings with the 
SEC, public conference calls, and webcasts. To subscribe to our e-mail alert service, please click the “Investor Alerts” link in the Investor Relations section of our website and submit your email address. The information contained in, or that may be accessed through, our website is not incorporated by reference into or a part of this document or any other report or document we file with or furnish to the 
SEC, and any references to our website are intended to be inactive textual references only.

Disclaimer: Forward-Looking Statements

Matters discussed in this release may constitute forward-looking statements that may be deemed to be “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect current views with respect to future events and financial performance and may include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. These statements may include words such as “believe,” “estimate,” “project,” “intend,” “expect,” “plan,” “anticipate,” and similar expressions in connection with any discussion of the timing or nature of future operating or financial performance or other events.

The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, examination of historical operating trends, data contained in our records and other data available from third parties. Although 
Eagle Bulk Shipping Inc. believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, 
Eagle Bulk Shipping Inc. cannot assure you that it will achieve or accomplish these expectations, beliefs or projections.

Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include the strength of world economies and currencies, general market conditions, including changes in charter hire rates and vessel values, changes as a result of COVID-19, including the availability and effectiveness of vaccines on a widespread basis and the impact of any mutations of the virus, changes in demand that may affect attitudes of time charterers to scheduled and unscheduled drydocking, changes in vessel operating expenses, including drydocking and insurance costs, or actions taken by regulatory authorities, ability of our counterparties to perform their obligations under sales agreements, charter contracts, and other agreements on a timely basis, potential liability from future litigation, domestic and international political conditions, potential disruption of shipping routes due to accidents and political events or acts by terrorists.

Risks and uncertainties are further described in reports filed by 
Eagle Bulk Shipping Inc. with the 
SEC.

CONTACT

Company Contact:
Frank De Costanzo
Chief Financial Officer

Eagle Bulk Shipping Inc.
Tel. +1 203-276-8100
Email: investor@eagleships.com

Media:

Rose and Company
Tel. +1 212-359-2228

Source: 
Eagle Bulk Shipping Inc.

Release – Euroseas Ltd. Sets Date for the Release of Second Quarter 2021 Results Conference Call and Webcast


Euroseas Ltd. Sets Date for the Release of Second Quarter 2021 Results, Conference Call and Webcast

 

ATHENS, Greece, Aug. 06, 2021 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today that it will release its financial results for the second quarter ended June 30, 2021 on Wednesday, August 11, 2021 after market closes in New York.

On the next day, Thursday, August 12, 2021 at 9:00 a.m. Eastern Time, the Company’s management will host a conference call and webcast to discuss the results.

Conference Call details:
Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1 (877) 553-9962 (US Toll Free Dial In), 0(808) 238-0669 (UK Toll Free Dial In) or +44 (0) 2071 928592 (Standard International Dial In). Please quote “Euroseas” to the operator.

To listen to the archived audio file, visit our website http://www.euroseas.gr and click on Company Presentations under our Investor Relations page. The audio replay of the conference call will remain available until Wednesday, August 18, 2021.

Audio Webcast ? Slides Presentation:
There will be a live and then archived audio webcast of the conference call, via the internet through the Euroseas website (www.euroseas.gr). Participants to the live webcast should register on the website approximately 10 minutes prior to the start of the webcast.

The slide presentation on the second quarter ended June 30, 2021 will also be available in PDF format minutes prior to the conference call and webcast, accessible on the company’s website (www.euroseas.gr) on the webcast page. Participants to the webcast can download the PDF presentation.

About Euroseas Ltd.
Euroseas Ltd. was formed on May 5, 2005 under the laws of the Republic of the Marshall Islands to consolidate the ship owning interests of the Pittas family of Athens, Greece, which has been in the shipping business over the past 140 years. Euroseas trades on the NASDAQ Capital Market under the ticker ESEA. Euroseas operates in the container shipping market. Euroseas’ operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship Management Company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. Euroseas employs its vessels on spot and period charters and through pool arrangements. The Company has a fleet of 14 vessels on the water, including 9 Feeder containerships and 5 Intermediate Container carriers and two feeder ships under newbuilding contracts. After the delivery of the latter two vessels, Euroseas 16 containerships will have a cargo capacity of 47,881 teu.

Visit the Company’s website www.euroseas.gr

Company Contact
Tasos Aslidis
Chief Financial Officer
Euroseas Ltd.
Canterbury Lane
Watchung, NJ 07069
Tel. (908) 301-9091
E-mail: aha@euroseas.gr 
Investor Relations / Financial Media
Nicolas Bornozis
President
Capital Link, Inc.
230 Park Avenue, Suite 1536
New York, NY 10169
Tel: (212) 661-7566
Email: euroseas@capitallink.com

Release – ACCO Brands Corporation Declares Quarterly Dividend


ACCO Brands Corporation Declares Quarterly Dividend

 

LAKE ZURICH, Ill.–(BUSINESS WIRE)– ACCO Brands Corporation (NYSE: ACCO) today announced that its board of directors has declared a quarterly cash dividend of $0.065 per share. The dividend will be paid on September 15, 2021, to stockholders of record as of the close of business on August 27, 2021.

About ACCO Brands Corporation

ACCO Brands Corporation is one of the world’s largest designers, marketers and manufacturers of branded academic, consumer and business products. Our widely recognized brands include AT-A-GLANCE®, Barrilito®, Derwent®, Esselte®, Five Star®, Foroni®, GBC®, Hilroy®, Kensington®, Leitz®, Mead®, PowerA®, Quartet®, Rapid®, Rexel®, Swingline®, Tilibra®, Wilson Jones®, and many others. Our products are sold in more than 100 countries around the world. More information about ACCO Brands, the Home of Great Brands Built by Great People, can be found at www.accobrands.com.

Christine Hanneman
Investor Relations
(847) 796-4320

Julie McEwan
Media Relations
(937) 974-8162

Source: ACCO Brands Corporation

Release – Aurania Announces Proposed Amendments to Certain Outstanding Unlisted Warrants


Aurania Announces Proposed Amendments to Certain Outstanding Unlisted Warrants

 

Toronto, Ontario, August 6, 2021 – Aurania Resources Ltd. (TSXV: ARU) (OTCQB: AUIAF) (Frankfurt: 20Q) (“Aurania” or the “Company”) announces that it is proposing to amend the terms of 1,043,567 common share purchase warrants (the “Warrants”) issued by the Company in connection with a private placement financing that closed in three tranches on February 28, March 5 and March 13, 2020.  The Warrants were issued during the early days of the COVID-19 global pandemic and carry an exercise price per share of C$4.25. The Warrants issued in each tranche of the private placement are scheduled to expire on August 28, September 5 and September 13, 2021, respectively.  The proposed amendments will include the following (the “Proposed Amendments”): (a) a reduction of the exercise price to C$3.40 per share issuable upon exercise of a Warrant; (b) an extension to the expiry date to March 13, 2022; and (c) an accelerated expiry provision, such that the Warrants will expire on the earlier of the extended expiry date and 30 days following the 10th consecutive trading day on which the closing price of Aurania’s shares exceeds the amended exercise price of the Warrants by 15% or more.

The Proposed Amendments are subject to the approval of the TSX Venture Exchange (the “TSXV”).  Subject to the approval of the TSXV, the Proposed Amendments will become effective automatically as of the original date and time of expiry of the Warrants. Prior to the original date and time of expiry of the Warrants, the Warrants will remain in force, unamended, per their original terms and conditions.  None of the Warrants are beneficially owned, directly or indirectly, by related parties of Aurania and none of the Warrants are listed on the TSXV. The Proposed Amendments do not apply to any Warrants issued to finders or agents as compensation.

Holders of the Warrants may contact the Company at ir@aurania.com or DSA Corporate Services, the administrator of the Warrants, should they have any questions or wish to exercise their Warrants.  Subject to the amendments becoming effective, the original certificate representing the Warrants, together with a duly completed exercise form, will be accepted together with payment made to Aurania Resources Ltd., in accordance with the instructions provided on the certificate representing the Warrants.

DSA Contact Details:

DSA Corporate Services Inc.

82 Richmond Street East, 4th Floor

Toronto, M5C 1P1

Phone: (416) 848-7744

info@dsacorp.ca

About Aurania

Aurania is a mineral exploration company engaged in the identification, evaluation, acquisition and exploration of mineral property interests, with a focus on precious metals and copper in South America.  Its flagship asset, The Lost Cities – Cutucu Project, is located in the Jurassic Metallogenic Belt in the eastern foothills of the Andes mountain range of southeastern Ecuador.

Information on Aurania and technical reports are available at www.aurania.com and www.sedar.com, as well as on Facebook at https://www.facebook.com/auranialtd/, Twitter at https://twitter.com/auranialtd, and LinkedIn at https://www.linkedin.com/company/aurania-resources-ltd-.

For further information, please contact:

Carolyn Muir

VP Investor Relations

Aurania Resources Ltd.

(416) 367-3200

carolyn.muir@aurania.com

Dr. Richard Spencer

President

Aurania Resources Ltd.

(416) 367-3200

richard.spencer@aurania.com

Forward-Looking Statements

This news release may contain forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurania. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to Aurania, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information.

Forward looking information in this news release includes, but is not limited to, statements regarding the Proposed Amendments and the approval of TSXV in respect of same. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, failure by the TSXV to approve the Proposed Amendments. Although Aurania believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Aurania disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Release – Ocugen Provides Business Update and Second Quarter 2021 Financial Results


Ocugen Provides Business Update and Second Quarter 2021 Financial Results

 

Conference Call and Webcast Today at 8:30 a.m. ET

  • Rolling regulatory submission to Health Canada completed and review process initiated; U.S. FDA talks continue
  • Multiple milestones achieved across regulatory and supply chain to support potential commercialization of pipeline assets
  • The Company experienced organizational growth to reflect new business requirements in clinical development, manufacturing, and commercialization

MALVERN, Pa., Aug. 06, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today reported second quarter 2021 financial results along with a general business update.

“The second quarter has proven how dynamic the life sciences sector is during this time of global crisis, and we are undeterred in our efforts to contribute to the public health agenda. Our regulatory submission to Health Canada and our ongoing discussions with the U.S. Food and Drug Administration continue to provide us direction in potentially obtaining regulatory approvals for COVAXIN™ in North America. We are also continuing our forward momentum to take on blindness diseases and are on track to initiate our first gene therapy clinical trial for OCU400 in the latter part of 2021. Overall, I’m very pleased with our growth and efforts to date,” said Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-Founder of Ocugen.

Business Highlights

FORWARD MOMENTUM FOR COVAXIN™ AND OPHTHALMIC PIPELINE

  • The Company’s partner, Bharat Biotech of India, completed and posted its Phase 3 clinical trial results for COVAXIN™ demonstrating 77.8% efficacy against overall COVID-19 disease, 93.4% efficacy against severe COVID-19 disease, 63.6% efficacy against asymptomatic COVID-19 disease, and 65.2% efficacy against the Delta variant, B.1.617.2. Adverse events in the COVAXIN™ and control arms of the Phase 3 clinical trial were observed in 12.4% of subjects, with less than 0.5% of subjects experiencing serious adverse side effects. This data was submitted to a peer-reviewed journal for future potential publication.
  • In June, an amendment to the agreement with Bharat Biotech was finalized which expanded the Company’s rights to develop, manufacture, and commercialize COVAXIN™ into Canada (in addition to the United States). Soon after in July, the Company announced the completion of its regulatory submission to Health Canada for COVAXIN™, which was accepted under the Minister of Health’s Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 and transitioned to a New Drug Submission for COVID-19. The submission was conducted through the Company’s new affiliate, Vaccigen, Ltd., and the review process has begun in Canada.
  • Discussions with the U.S. Food and Drug Administration are ongoing, and the Company is still proceeding with a strategy focused on the agency’s requested Biologics License Application pathway and determining what data requirements and U.S.-based clinical trials will be required to support such submission.
  • Technology transfer activities are ongoing between Bharat Biotech and Jubilant HollisterStier, which the Company has selected to be its contract manufacturing partner with respect to COVAXIN™.
  • The Company’s development activities targeting retinal diseases based on its breakthrough modifier gene therapy platform continue to progress. Its first candidate therapy, OCU400, is anticipated to move into two parallel Phase 1/2a clinical trials in the United States later this year. The Company is currently also evaluating options to commence OCU400 clinical trials in Europe in 2022.

COMPANY POSITIONING FOR FUTURE GROWTH

  • New management team member, Mike Shine, joined the Company in early June as Senior Vice President, Commercial, bringing nearly 35 years of industry experience. Mr. Shine will lead commercial efforts for the Company’s portfolio including COVAXIN™’s launch in Canada and the United States, if authorized or approved.
  • Employee count has grown as the Company establishes enhanced capabilities in Research and Development, Clinical Development, Commercial, Supply Chain, and Communications.
  • The Company entered the Russell 2000 and 3000 Indices in June, which reflects the organization’s performance, growth, and value.

Second Quarter 2021 Financial Results

  • Ocugen’s cash, cash equivalents, and restricted cash totaled $115.8 million as of June 30, 2021, compared to $24.2 million as of December 31, 2020. Ocugen had 198.7 million shares of common stock outstanding as of June 30, 2021.
  • Research and development expenses for the three months ended June 30, 2021 were $18.9 million compared to $1.6 million for the three months ended June 30, 2020. Research and development expenses for the three months ended June 30, 2021 included a $15.0 million up-front payment to Bharat Biotech for the right and license to COVAXIN™ development, manufacturing, and commercialization in Canada. General and administrative expenses for the three months ended June 30, 2021 were $6.8 million compared to $1.8 million for the three months ended June 30, 2020. Ocugen reported a $0.13 net loss per share for the three months ended June 30, 2021 compared to a $0.19 net loss per share for the three months ended June 30, 2020.

Conference Call and Webcast Details

Ocugen has scheduled a conference call and webcast for 8:30 a.m. eastern time today to discuss the financial results and recent business highlights. Ocugen’s senior management team will host the call, which will be open to all listeners. There will also be a question-and-answer session following the prepared remarks.

The call can be accessed by dialing (844) 873-7330 (U.S.) or (602) 563-8473 (international) and providing the conference ID 6663619. To access a live audio webcast of the call on the “Investors” section of the Ocugen website, please click here. A replay of the webcast will be archived on Ocugen’s website for approximately 45 days following the call.

About Ocugen, Inc.
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing?a vaccine to?save lives from COVID-19. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many” and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy.?We are co-developing Bharat Biotech’s COVAXIN™ vaccine candidate for COVID-19 in the U.S. and Canadian markets.?For more information, please visit www.ocugen.com.

Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such forward-looking statements include information about qualitative assessments of available data, potential benefits, expectations for clinical trials, and anticipated timing of clinical trial readouts and regulatory submissions. This information involves risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, including the risk that such dates are not met due to impacts from the ongoing COVID-19 pandemic, as well as risks associated with preliminary and interim data, including the possibility of unfavorable new clinical trial data and further analyses of existing clinical trial data; the risk that the results of in-vitro studies will not be duplicated in human clinical trials; the risk that clinical trial data are subject to differing interpretations and assessments, including during the peer review/publication process, in the scientific community generally, and by regulatory authorities; whether and when data from Bharat Biotech’s clinical trials will be published in scientific journal publications and, if so, when and with what modifications; whether we will be able to provide the U.S. Food and Drug Administration (“FDA”) with sufficient additional information regarding the design of and results from preclinical and clinical studies of COVAXIN™, which have been conducted by Bharat Biotech in India in order for those trials to support a Biologics License Application (“BLA”); the size, scope, timing and outcome of any additional trials or studies that we may be required to conduct to support a BLA; any additional chemistry, manufacturing, and controls information that we may be required to submit; the timing of our BLA filing; whether and when a BLA for COVAXIN™ will be submitted to the FDA; whether and when a BLA may be approved by the FDA, an application for authorization under the Interim Order for emergency use may be approved by Health Canada, or a New Drug Submission application may be approved by Health Canada, which authorizations or approvals will depend on myriad factors, including making a determination as to whether the vaccine candidate’s benefits outweigh its known risks and determination of the vaccine candidate’s efficacy and, if authorized or approved, whether it will be commercially successful; whether developments with respect to the COVID-19 pandemic will affect the regulatory pathway available for vaccines in the United States, Canada, or other jurisdictions; manufacturing capabilities, manufacturing capacity, and supply restrictions, including whether sufficient doses of COVAXIN™ can be manufactured or supplied within our projected time periods; market demand for COVAXIN™ in the United States or Canada; decisions by the FDA or Health Canada impacting labeling, manufacturing processes, safety, and/or other matters that could affect the availability or commercial potential of COVAXIN™ in the United States or Canada, including development of products or therapies by other companies. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (“SEC”), including the risk factors described in the section entitled “Risk Factors” in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.

Ocugen Contact:
Ken Inchausti
Head, Investor Relations & Communications
+1 484 237 3398
ken.inchausti@ocugen.com

Please submit investor-related inquiries to: IR@ocugen.com

(tables to follow)

OCUGEN, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands)

(Unaudited)

  June 30, 2021   December 31, 2020
Assets      
Current assets      
Cash and cash equivalents $ 115,642       $ 24,039    
Advance for COVAXIN supply 4,988          
Prepaid expenses and other current assets 996       1,839    
Total current assets 121,626       25,878    
Property and equipment, net 944       633    
Restricted cash 151       151    
Other assets 1,530       714    
Total assets $ 124,251       $ 27,376    
Liabilities and stockholders’ equity      
Current liabilities      
Accounts payable $ 802       $ 395    
Accrued expenses and other current liabilities 3,870       2,941    
Short-term debt, net       234    
Operating lease obligation 168       44    
Total current liabilities 4,840       3,614    
Non-current liabilities      
Operating lease obligation, less current portion 1,328       389    
Long term debt, net 1,674       1,823    
Total liabilities 7,842       5,826    
Stockholders’ equity      
Convertible preferred stock 1          
Common stock 1,988       1,841    
Treasury stock (48 )     (48 )  
Additional paid-in capital 220,799       93,059    
Accumulated deficit (106,331 )     (73,302 )  
Total stockholders’ equity 116,409       21,550    
Total liabilities and stockholders’ equity $ 124,251       $ 27,376    


OCUGEN, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share amounts)

(Unaudited)

  Three months ended June 30,   Six months ended June 30,
  2021   2020   2021   2020
Revenues              
Collaboration revenue $       $ 43       $       $ 43    
Total revenues       43             43    
Operating expenses              
Research and development 18,853       1,630       21,725       3,282    
General and administrative 6,757       1,779       10,942       4,056    
Total operating expenses 25,610       3,409       32,667       7,338    
Loss from operations (25,610 )     (3,366 )     (32,667 )     (7,295 )  
Other income (expense)              
Interest income 10             10          
Interest expense (20 )     (248 )     (40 )     (263 )  
Other income (expense) (332 )           (332 )        
Total other income (expense) (342 )     (248 )     (362 )     (263 )  
Net loss $ (25,952 )     $ (3,614 )     $ (33,029 )     $ (7,558 )  
Deemed dividend related to Warrant Exchange       (12,546 )           (12,546 )  
Net loss to common stockholders $ (25,952 )     $ (16,160 )     $ (33,029 )     $ (20,104 )  
               
Shares used in calculating net loss per common share — basic and diluted 195,572,189       83,537,463       190,960,775       68,082,346    
Net loss per share of common stock — basic and diluted $ (0.13 )     $ (0.19 )     $ (0.17 )     $ (0.30 )  

 

Release – enCore Energy Corp. Announces Clarification on Uranium Sales Agreement News Release


enCore Energy Corp. Announces Clarification on Uranium Sales Agreement News Release

 

CORPUS CHRISTI, TexasAug. 4, 2021 /PRNewswire/ – enCore Energy Corp. (TSXV: EU) (OTCQB: ENCUF) (the “Company“)   announces, for greater clarity, as stated in the August 4, 2021 news release, the Company’s objective is to advance its South Texas uranium facilities towards production and as such has executed a uranium sales agreement. The Agreement covers a total of 2 million pounds U3O8 at market related prices over a 5-year period starting in 2023.

About enCore Energy Corp.

enCore Energy Corp. is a U.S. domestic uranium developer focused on becoming a leading in-situ recovery (ISR) uranium producer. The Company is led by a team of industry experts with extensive knowledge and experience in the development and operations of in situ recovery uranium operations. enCore Energy’s opportunities are created from the Company’s transformational acquisition of its two South Texas production facilities, the changing global uranium supply/demand outlook and opportunities for industry consolidation.  These short-term opportunities are augmented by our strong long term commitment to working with local indigenous communities in New Mexico where the company holds significant uranium resources.

SOURCE enCore Energy Corp.

DLH Holdings Corp. (DLHC) – Post Call Update – A Deeper Dive

Friday, August 06, 2021

DLH Holdings (DLHC)
Post Call Update – A Deeper Dive

DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of veteran affairs, Department of health and human services, Department of Defense and other government agencies. It operates primarily through prime contracts and also derives its revenue from agencies of the federal government, primarily as a prime contractor but also as a subcontractor to other Federal prime contractors.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Organic Growth Returns. DLH reported an estimated $2.8 million of organic growth in the quarter. Organic growth has faced headwinds from the absence of pass thru travel revenue due to COVID (which still hasn’t fully returned) and an expected reduction in scope of a HHS contract as the prior contract contained funds for an IT upgrade, which DLH successfully completed. We estimate this headwind at about $7 million annually over the five year contract term.

    VA Logistics.  While we are disappointed the protest of the award continues to drag on, we are hopeful it will be resolved soon. We continue to believe DLH is well positioned to retain the contract given the quality and cost effectiveness DLH brings to the contract …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Genco Shipping (GNK) – Fine Tuning EBITDA Estimates Following 2Q2021 Earnings Call

Friday, August 06, 2021

Genco Shipping (GNK)
Fine Tuning EBITDA Estimates Following 2Q2021 Earnings Call

Genco Shipping & Trading Limited, incorporated on September 27, 2004, transports iron ore, coal, grain, steel products and other drybulk cargoes along shipping routes through the ownership and operation of drybulk carrier vessels. The Company is engaged in the ocean transportation of drybulk cargoes around the world through the ownership and operation of drybulk carrier vessels. As of December 31, 2016, its fleet consisted of 61 drybulk carriers, including 13 Capesize, six Panamax, four Ultramax, 21 Supramax, two Handymax and 15 Handysize drybulk carriers, with an aggregate carrying capacity of approximately 4,735,000 deadweight tons (dwt). Of the vessels in its fleet, 15 are on spot market-related time charters, and 27 are on fixed-rate time charter contracts. As of December 31, 2016, additionally, 19 of the vessels in its fleet were operating in vessel pools.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Fine tuning 2021 EBITDA estimate to $203 million on TCE rate assumptions of $20.7k/day. Forward cover remains high at 71% of 3Q2021 available days booked at TCE rates that are much higher at $27.6k/day. Three new time charters signed, but visibility is limited beyond one quarter out.

    Our FY2022 dividend estimate has moved up to $3.05/share from our original estimate of $2.25/share, or a potential yield of ~17%.  The dividend estimate increase is driven by our higher 2022 EBITDA estimate of $226 million and higher TCE rates of $21.6k/day …



This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Entravision Communications Corporation (EVC) – A Chocolate Covered Quarter With Sprinkles

Friday, August 06, 2021

Entravision Communications Corporation (EVC)
A Chocolate Covered Quarter With Sprinkles

Entravision Communications Corporation is a diversified Spanish-language media company utilizing a combination of television and radio operations to reach Hispanic consumers across the United States, as well as the border markets of Mexico. Entravision owns and/or operates 53 primary television stations and is the largest affiliate group of both the top-ranked Univision television network and Univision’s TeleFutura network, with television stations in 20 of the nation’s top 50 Hispanic markets. The Company also operates one of the nation’s largest groups of primarily Spanish-language radio stations, consisting of 48 owned and operated radio stations.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Q2 results exceed expectations. Total company revenues of $178.4 million was 9% above our $163.1 million estimate, driven by exceptional 1,045% growth in Digital revenues and a solid 108% revenue growth in its Audio (Radio) businesses. Even its TV had a solid revenue performance, up 26%. Adj. EBITDA exceeded expectations $17.8 million versus our $16.1 million estimate.

    Solidly, a digital media company.  Combined with recent acquisitions, Digital represents 73% of total company revenues. The recent acquisition of MediaDonuts is expected to augment the strong growth of its acquired Cisneros Interactive business …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Eagle Bulk Shipping (EGLE) – 2Q2021 Results Way Above Expectations and Strong Forward Cover

Friday, August 06, 2021

Eagle Bulk Shipping (EGLE)
2Q2021 Results Way Above Expectations and Strong Forward Cover

Eagle Bulk Shipping Inc. is a US-based drybulk owner-operator focused on the Supramax/Ultramax mid-size asset class, which ranges from 50,000 and 65,000 deadweight tons in size; these vessels are equipped with onboard cranes allowing for the self-loading and unloading of cargoes, a feature which distinguishes them from the larger classes of drybulk vessels and provides for greatly enhanced flexibility and versatility- both with respect to cargo diversity and port accessibility. The Company transports a broad range of major and minor bulk cargoes around the world, including coal, grain, ore, pet coke, cement, and fertilizer. Eagle operates out of three offices, Stamford (headquarters), Singapore, and Hamburg, and performs all aspects of vessel management in-house including: commercial, operational, technical, and strategic.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Strong 2Q2021 operating results masked by FFA losses. Call with management today at 8am EST—number is 844-282-441 and code is 3636539. After backing out FFA hedges and other items of $31.6 million, adjusted EBITDA of $62.8 million was well ahead of expectations. TCE revenue of $93 million and TCE rates of $21.6k/day were above expectations, while opex were in line.

    Moving 2021 EBITDA to $255 million (from $216 million) based on TCE rates of $22.1k/day to reflect higher 2Q2021 results and high forward cover with about 75% of 3Q2021 available days are booked at TCE rates of $28.3k/day.  2022 EBITDA also moves higher to $267.2 million (from $233 million) based on TCE rates of $22.0k/day …



This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Allegiant Gold (AUXXF)(AUAU:CA) – Methodical Approach Leads to Favorable Outcomes

Friday, August 06, 2021

Allegiant Gold (AUXXF)(AUAU:CA)
Methodical Approach Leads to Favorable Outcomes

Allegiant Gold Ltd is a gold exploration company. Its project profile consists of Bolo, Browns Canyon, Clara Moro, Four Metals, Monitor Hills, Red Hills, Silver Dome, West Goldfield, White Horse Flats, Mogollon, Eastside, Dutch Flat, and others.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Equity financing provides financial flexibility. Allegiant Gold raised gross proceeds of C$5.0 million with the issuance of 12,500,000 units in a bought deal that is expected to close on August 17. Net proceeds amount to C$4.7 million after deducting the underwriters’ fee but before deducting expenses of the offering which are estimated to be C$300 thousand and will be paid from proceeds of the offering. The underwriters have an option to purchase an additional 1,875,000 units up to 30 days following the closing of the offering. Each unit consists of one common share and one-half of one common share purchase warrant.

    Inferred gold resources increase 41%.  Allegiant released an updated resource estimate and NI 43-101 technical report for the Eastside and Castle properties in Nevada. Eastside inferred gold resources total 1,090,000 gold ounces and 8,700,000 silver ounces, while Castle inferred resources total 314,000 gold ounces. Inferred gold resources increased 41% compared to the previous NI 43-101 which …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision.